manufacturer prevacid

April 1, 2008 (Chicago) -- A trial of the statin drug Crestor has been halted early due to "unequivocal evidence" that it reduces heart attacks, strokes, and deaths due to cardiovascular disease in people with no signs of heart disease, says manufacturer AstraZeneca. The details of the trial have not yet been released. But another study presented at the annual meeting of the American College of Cardiology (ACC) shows that Crestor slows the buildup of plaque that can lead to a heart attack.. prevacid in children astrazeneca prevacid prilosec verses prevacid prevacid blocks calcium absorption prevacid iv dosing